abstract |
The present invention relates to a novel epitope of human ADAM12 and to binding agents, preferably to Fab fragments, specifically binding to said epitope. The invention also relates to a method for detecting ADAM 12 in a biological sample using said binding agents, and to prenatal screening methods and diagnostic methods using said binding agents. |